Immunomodulators
These sections summarize data on corticosteroids, IL-6 inhibitors, JAK inhibitors, and other immunomodulators.
Recommendations for the use of immunomodulators in patients with COVID-19
Information on the use of anti-inflammatory drugs as treatment for COVID-19
Information on COVID-19 studies that evaluated the use of inhaled corticosteroids
Information on the use of IL-6 inhibitors as treatment for COVID-19
Information on the use of JAK inhibitors as treatment for COVID-19
Information on the use of abatacept as treatment for COVID-19
Information on the use of infliximab as treatment for COVID-19
Information on COVID-19 studies that evaluated the use of IL-1 inhibitors
Information on COVID-19 studies that evaluated the use of vilobelimab
Characteristics of immunomodulators evaluated in COVID-19 clinical trials